Status:

RECRUITING

Inflammatory faCtors AfteR acUte Ischemic Stroke

Lead Sponsor:

Martin Dichgans

Collaborating Sponsors:

Universitätsklinikum Hamburg-Eppendorf

University Hospital Muenster

Conditions:

Ischemic Stroke

Eligibility:

All Genders

50+ years

Phase:

NA

Brief Summary

ICARUS is an interventional single-centre hospital-based cohort study in patients admitted to the stroke unit with an acute ischemic stroke. The aims of the study are to i) define the characteristics ...

Detailed Description

The neuroinflammatory response after ischemic brain injury has been identified as a pathomechanism in ischemic stroke. Stroke induces an activation of microglia in the brain, which lasts over months. ...

Eligibility Criteria

Inclusion

  • Age ≥ 50 years
  • Acute ischemic stroke (time frame: \<72 hours) as defined by an acute focal neurological deficit in combination with a corresponding infarct as documented by a diffusion weighted imaging (DWI)-positive lesion on magnetic resonance imaging (MRI); presence of an infarct involving the cortex or a strictly subcortical infarct
  • Written informed consent prior to study participation
  • Willingness to participate in study assessments including follow-up

Exclusion

  • Unwillingness or inability to give written consent
  • Prior history of stroke, multiple infarcts, infratentorial infarcts affecting the brain stem or cerebellum
  • Known diseases of the CNS other than stroke
  • Immunomodulatory therapies within the last 3 months prior stroke
  • Chronic inflammatory disease
  • Infectious diseases within the last 7 days prior stroke
  • Conditions interfering with follow-up such as end-stage malignancy
  • Contraindications for MRI or PET (pacemaker, aneurysm clip, cochlear implant etc.)
  • Radiation exposure of \> 10mSv per year
  • Pregnant or breastfeeding women
  • Participation in a clinical trial

Key Trial Info

Start Date :

July 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2027

Estimated Enrollment :

36 Patients enrolled

Trial Details

Trial ID

NCT04412187

Start Date

July 1 2020

End Date

December 31 2027

Last Update

April 4 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Insitute for Stroke and Dementia Research

Munich, Germany, Germany, 81377

2

Department of Nuclear Medicine

Munich, Germany, 81377